Betagenon AB: AMPK Activator O304, 3-in-1 Drug

STOCKHOLM--(BUSINESS WIRE)--The benefits of physical activity on general health especially in elderly, makes it a desirable, yet elusive goal to identify orally active drugs that would mimic the effects of exercise on endurance and on metabolic and other diseases. Similarly, drugs that could stimulate the disposal of excess calories/fat in the absence of exercise would be helpful in combating the epidemic increase in obesity that is associated with a western diet and sedentary life style. The generation and/or activation of brown fat which instead of storing calories as fat disposes of excess calories as heat under non-exercise conditions would be an attractive approach to achieve this goal. Thirdly, a drug that could lower blood glucose levels and mitigate associated metabolic and cardiovascular co-morbidities in obese individuals suffering from the metabolic syndrome would be of great benefit.